Enzymaster, a global biotech company with locations in China, Germany and Singapore specialized in biocatalysis and enzyme engineering, announced the close of a US$ 7.5 Mio (CNY 50 Mio) Series B-1 funding. The money has been raised from the Chinese investment firms Weifang Zhongke Haichuang Equity Investment Partnership, Tibet Leimerious Venture Investment Partnership, and Caozhixing […]
Interested in learning more about our services around biocatalysis or our products? We invite you to meet us at the 3rd ECP Summer Summit from September 17th to 18th . This year’s ECP presents itself in a fully digital format and we are looking forward to connect and expand our network of collaborations and partnerships!